- Home
- GTEC vs LIXT Comparison
GTEC vs LIXT Comparison
Compare GTEC & LIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- LIXT
- Stock Information
- Founded
- GTEC 2006
- LIXT 2005
- Country
- GTEC United States
- LIXT United States
- Employees
- GTEC N/A
- LIXT N/A
- Industry
- GTEC Industrial Machinery/Components
- LIXT Biotechnology: Pharmaceutical Preparations
- Sector
- GTEC Industrials
- LIXT Health Care
- Exchange
- GTEC Nasdaq
- LIXT Nasdaq
- Market Cap
- GTEC 21.0M
- LIXT 20.5M
- IPO Year
- GTEC N/A
- LIXT N/A
- Fundamental
- Price
- GTEC $1.00
- LIXT $4.25
- Analyst Decision
- GTEC
- LIXT
- Analyst Count
- GTEC 0
- LIXT 0
- Target Price
- GTEC N/A
- LIXT N/A
- AVG Volume (30 Days)
- GTEC 143.5K
- LIXT 115.0K
- Earning Date
- GTEC 11-07-2025
- LIXT 11-07-2025
- Dividend Yield
- GTEC N/A
- LIXT N/A
- EPS Growth
- GTEC N/A
- LIXT N/A
- EPS
- GTEC 0.91
- LIXT N/A
- Revenue
- GTEC $86,168,664.00
- LIXT N/A
- Revenue This Year
- GTEC $3.28
- LIXT N/A
- Revenue Next Year
- GTEC N/A
- LIXT N/A
- P/E Ratio
- GTEC $1.10
- LIXT N/A
- Revenue Growth
- GTEC N/A
- LIXT N/A
- 52 Week Low
- GTEC $0.92
- LIXT $0.64
- 52 Week High
- GTEC $2.92
- LIXT $6.26
- Technical
- Relative Strength Index (RSI)
- GTEC 32.18
- LIXT 44.90
- Support Level
- GTEC $0.92
- LIXT $3.84
- Resistance Level
- GTEC $1.21
- LIXT $4.45
- Average True Range (ATR)
- GTEC 0.07
- LIXT 0.32
- MACD
- GTEC -0.02
- LIXT -0.01
- Stochastic Oscillator
- GTEC 21.94
- LIXT 52.78
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About LIXT Lixte Biotechnology Holdings Inc.
Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.